Cartalax

Size

20 in stock · 20mg per vial

Description

Cartalax is a short-chain peptide bioregulator designed to restore and protect cartilage, joints, and connective tissue at the cellular level. It works by normalizing protein synthesis in chondrocytes, helping repair wear-and-tear, ease joint stiffness, and support long-term mobility and spine health.

Research

* Mechanism of Action: Cartalax is a synthetic tripeptide (Ala-Glu-Asp) that acts as an epigenetic regulator. It penetrates cell nuclei in chondrocytes (cartilage cells) to normalize gene expression and restore native protein synthesis. * Extracellular Matrix Support: Studies demonstrate that it stimulates the production of collagen (specifically type II) and proteoglycans/aggrecans, which are the fundamental structural components required for shock absorption in cartilage. * Primary Research Areas: Extensively studied for joint cartilage wear and tear, osteoarthritis, spinal disc degeneration, connective tissue remodeling, and recovery following orthopedic trauma or surgery. * Anti-Degenerative Properties: Research indicates it helps slow the apoptosis (premature cellular death) of cartilage cells and dampens localized inflammatory cascades within synovial joints. * Cycling Protocols in Literature: Unlike standard peptides that run for months, bioregulators are typically researched in short, focused courses—commonly 10 to 20 days (at 1mg to 2mg daily), repeated once or twice per year to maintain tissue health. * Stacking Synergy: In regenerative studies, it is frequently paired with systemic healing peptides like our GLOW Blend or Wolverine Blend to combine cellular bioregulation with active vascular and tissue repair.